Neuroimaging study reveals people who report widespread pain have increased gray matter and functional connectivity in sensory and motor areas of the brain.
The death of myelin producing oligodendrocytes appears to trigger multiple sclerosis like symptoms in mice, a new study reports.
A new study reports only half of infants under three months of age who have bacterial meningitis show traditional symptoms of the disease, such as high fever.
CRISPR gene editing created the G795A amino acid which was introduced to microglia derived from human stem cells. Researchers were able to transplant the donor microglia immune cells into humanized rodent models while administering an FDA-approved cancer drug called pexidartinib. The inclusion of the amino acid cause the donated microglia to thrive and resist the drug, while the host microglia died. The findings open the door for new methods of using microglia to treat a range of neurodegenerative disorders.
Researchers report the gene that encodes Ryk enhances the ability to remodel neural circuits and recover fine motor control following spinal cord injury.
From losing the sense of taste or smell to developing an increased risk of stroke, researchers investigate both the known and potential long-term implications of COVID-19 infection in the brain.
Researchers have developed a novel 3D printed scaffolding that mimics natural anatomy and boost stem cell treatment for spinal cord repair. While the initial scaffolds have been designed for rat models of SCI, researchers report the approach is scalable to humans.
Psychological symptoms, such as depression and anxiety, may be a sign COVID-19 is affecting the central nervous system of patients, a new study reports.
Dopamine may play a role in activating immune cells to migrate in the early stages of infection.
Researchers uncover beneficial effects of immune cells in myelin repair that could reverse myelin damage in multiple sclerosis.
DBS Plus, a new version of deep brain stimulation, shows promise in helping to relieve Parkinson's symptoms.
Researchers improve the recovery of function in mice following spinal cord injury.
